StockNews.com Begins Coverage on Mannatech (NASDAQ:MTEX)

StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX) in a research note released on Saturday morning. The firm issued a buy rating on the stock.

Mannatech Stock Up 5.1 %

Shares of NASDAQ MTEX opened at $8.50 on Friday. Mannatech has a 1 year low of $6.75 and a 1 year high of $10.51. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.17 and a quick ratio of 0.62. The company has a 50-day moving average price of $7.71 and a 200-day moving average price of $7.55. The stock has a market capitalization of $16.02 million, a P/E ratio of -13.49 and a beta of 1.17.

Mannatech (NASDAQ:MTEX) last released its earnings results on Tuesday, August 13th. The company reported ($0.33) earnings per share for the quarter. The company had revenue of $27.74 million during the quarter. Mannatech had a negative net margin of 0.97% and a negative return on equity of 11.87%.

Insider Buying and Selling

In related news, Director Larry A. Jobe sold 16,288 shares of the company’s stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $7.75, for a total transaction of $126,232.00. Following the sale, the director now owns 54,721 shares of the company’s stock, valued at approximately $424,087.75. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 41.50% of the stock is currently owned by insiders.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.